Tri-modal therapy (TMT) is an under-utilized, organ-sparing alternative to cystectomy for some patients with muscle-invasive bladder cancer which offers outcomes comparable to surgery and relatively favorable long-term quality of life measures. Our article “Current Landscape and Future Directions on Bladder Sparing Approaches to Muscle-Invasive Bladder Cancer” summarizes the existing literature on TMT and provides insight into future directions. It is our hope that this article improves awareness of this valuable treatment modality and ultimately increases the likelihood of bladder cancer patients being offered curative-intent therapy.
Written by: James Broughman, MD, Winston Vuong, MD, Omar Mian, MD, PhD, Department of Radiation Oncology, Cleveland Clinic, Cleveland, Ohio
Read the Abstract
T2 Muscle-Invasive Bladder Cancer: Tri-Modality Therapy (TMT) versus Radical Cystectomy - Stephen Williams & Nick James
Comparative Analyses of Costs and Survival Between Radical Cystectomy and Trimodal Therapy - Stephen Williams